Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study

医学 肝细胞癌 倾向得分匹配 内科学 胃肠病学 阶段(地层学) 回顾性队列研究 总体生存率 队列 完全响应 肝癌 存活率 肝切除术 外科 切除术 化疗 生物 古生物学
作者
Zili Hu,Xiaohui Wang,Yizhen Fu,Dinghua Yang,Zhongguo Zhou,Minshan Chen,Xin Song,Yaojun Zhang
出处
期刊:International Journal of Surgery [Wolters Kluwer]
卷期号:110 (2): 1019-1027 被引量:3
标识
DOI:10.1097/js9.0000000000000942
摘要

Background: High rate of tumor recurrence jeopardized the long-term survival of hepatocellular carcinoma (HCC) patients with complete response to transarterial chemoembolization (TACE). This study aims to evaluate the survival benefit of liver resection (LR) following the complete response to TACE for intermediate-stage HCC. Methods: A total of 281 intermediate-stage HCC patients with complete response to TACE followed by persistent observation (TACE group) or LR (TLR group) from 01 January 2011 to 31 December 2021 from three institutions in China were included. Overall survival (OS) and disease-free survival (DFS) of patients were compared between the two groups by propensity score–matching (PSM). Results: After PSM, the 1-year, 3-year, and 5-year OS rates were 91.4, 71.5, and 57.1% in the TACE group, and 96.6, 81.8, and 72.1% in the TLR group. The 1-year, 3-year, and 5-year DFS rates were 50.6, 22.6, and 6.8% in the TACE group, and 77.3, 56.3, and 38.7% in the TLR group. Compared with the TACE group, the TLR group showed significantly longer OS (HR, 0.528; 95% CI: 0.315–0.887; P =0.014) and DFS (HR, 0.388; 95% CI: 0.260–0.580; P <0.001). In patients beyond up-to-seven criterion, no difference was observed with OS (HR, 0.708; 95% CI: 0.354–1.419; P =0.329). LR following the complete response to TACE was safety. Conclusions: This study suggests that intermediate-stage HCC patients could benefit from LR following the complete response to TACE, resulting in longer OS and DFS. In addition, patients beyond up-to-seven could not benefit from the LR treatments.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
所所应助平淡的沛儿采纳,获得10
刚刚
1秒前
王铎完成签到,获得积分10
1秒前
2秒前
李雪蒙发布了新的文献求助10
2秒前
言之妈妈发布了新的文献求助10
2秒前
一颗煤炭完成签到 ,获得积分10
2秒前
ajxtt发布了新的文献求助10
3秒前
落后觅云发布了新的文献求助10
4秒前
4秒前
summitekey完成签到 ,获得积分10
4秒前
4秒前
不曾留步发布了新的文献求助10
4秒前
wu完成签到,获得积分10
4秒前
5秒前
5秒前
Maerang发布了新的文献求助10
5秒前
6秒前
6秒前
ljxx发布了新的文献求助10
6秒前
朝气发布了新的文献求助10
6秒前
7秒前
在水一方应助犹豫忆南采纳,获得10
8秒前
艽野发布了新的文献求助10
8秒前
8秒前
sky发布了新的文献求助10
9秒前
mianbao完成签到,获得积分10
11秒前
ccc发布了新的文献求助10
11秒前
hilknk完成签到,获得积分10
11秒前
言之妈妈完成签到,获得积分10
12秒前
ll发布了新的文献求助10
12秒前
12秒前
小黄包子完成签到,获得积分10
12秒前
12秒前
CodeCraft应助舒服的山晴采纳,获得10
12秒前
彭桢发布了新的文献求助10
13秒前
13秒前
Qiuyajing完成签到,获得积分10
13秒前
14秒前
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969322
求助须知:如何正确求助?哪些是违规求助? 3514152
关于积分的说明 11172188
捐赠科研通 3249407
什么是DOI,文献DOI怎么找? 1794832
邀请新用户注册赠送积分活动 875437
科研通“疑难数据库(出版商)”最低求助积分说明 804781